Melinda Griffith's most recent trade in Insight Molecular Diagnostics Inc. was a trade of 45,000 Option to Purchase Common Stock done . Disclosure was reported to the exchange on Aug. 15, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Insight Molecular Diagnost... | Melinda Griffith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 45,000 | 45,000 | - | - | Option to Purchase Common Stock | |
| Insight Molecular Diagnost... | Melinda Griffith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 10,000 | 20,000 (0%) | 0% | 0 | Common Stock, no par value | |
| Insight Molecular Diagnost... | Melinda Griffith | Director | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 15 Aug 2022 | 10,000 | 30,000 (0%) | 0% | 1 | 10,000 | Common Stock, no par value |
| Insight Molecular Diagnost... | Melinda Griffith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2022 | 10,000 | 0 | - | - | Restricted Stock Units | |
| Insight Molecular Diagnost... | Melinda Griffith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2022 | 10,000 | 10,000 (0%) | 0% | 0 | Common Stock, no par value | |
| Insight Molecular Diagnost... | Melinda Griffith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 45,000 | 45,000 | - | - | Option to Purchase Common Stock | |
| Insight Molecular Diagnost... | Melinda Griffith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 10,000 | 10,000 | - | - | Restricted Stock Units |